1. Miyoshi K, Miyamura T, Kobayashi T, et al. Hypergammaglobulinemia by prolonged adjuvanticity in men: disorders developed after augmentation mammoplasty. J Keio Med Soc 1964;2122:9–14.
2. Baldwin CM Jr, Kaplan EN. Silicone-induced human adjuvant disease? Ann Plast Surg 1983;10:270–3.
3. Cardenas-Camarena L. Managing the mammary gland infiltrated with foreign substances: different surgical alternatives. Ann Plast Surg 2009;62:621–6.
5. Martinez-Villarreal AA, Asz-Sigall D, Gutierrez-Mendoza D, et al. A case series and a review of the literature on foreign modelling agent reaction: an emerging problem. Int Wound J 2017;14:546–54.
6. Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, et al. Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld’s syndrome). Lupus 2012;21:128–35.
7. Shoenfeld Y, Agmon-Levin N. ‘ASIA’: autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011;36:4–8.
8. Vera-Lastra O, Medina G, Cruz-Dominguez MP, et al. Autoimmune/inflammatory syndrome induced by mineral oil: a health problem. Clin Rheumatol 2018;37:1441–8.
9. Cohen Tervaert JW. Autoinflammatory/autoimmunity syndrome induced by adjuvants (ASIA; Shoenfeld’s syndrome): a new flame. Autoimmun Rev 2018;17:1259–64.
10. Vera-Lastra O, Hernadez PB, Sanchez-Rodriguez A, et al. AB0991 Prevalence of fibromyalgia and depression in patients with autoimmune/inflammatory syndrome induced by adjuvants compared to patients with systemic sclerosis. Ann Rheum Dis 2017;76(Suppl 2):1401.
11. Petry T, Bury D, Fautz R, et al. Review of data on the dermal penetration of mineral oils and waxes used in cosmetic applications. Toxicol Lett 2017;280:70–8.
12. Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol 2013;9:361–73.
14. Dagan A, Kogan M, Shoenfeld Y, et al. When uncommon and common coalesce: adult onset Still’s disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA). Clin Rheumatol 2016;35:1643–8.
15. Grippaudo FR, Spalvieri C, Rossi A, et al. Ultrasound-assisted liposuction for the removal of siliconomas. Scand J Plast Reconstr Surg Hand Surg 2004;38:21–6.
16. Bassetto F, Abatangelo S, Masetto L, et al. Ultrasound-assisted liposuction as a safe and effective method for the removal of siliconomas. Aesthetic Plast Surg 2012;36:220–2.
17. Park TH, Seo SW, Kim JK, et al. Clinical outcome in a series of 173 cases of foreign body granuloma: improved outcomes with a novel surgical technique. J Plast Reconstr Aesthet Surg 2012;65:29–34.
18. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208.
19. Colaris MJL, de Boer M, van der Hulst RR, et al. Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature. Immunol Res 2017;65:120–8.
20. Zandi I. Removal of soft tissue injected with liquid silicone with an ultrasound-suction system. Plast Reconstr Surg 2001;107:1077.
22. Schenone GE. Bioethical considerations. In: Schenone G editors. Injection-induced breast siliconomas. Cham: Springer; 2020. p.271–88.
23. Janssen B, Szende A. Population Norms for the EQ-5D. In: Szende A, Janssen B, Cabases J editors. Self-reported population health: an international perspective based on EQ-5D. Dordrecht: Springer; 2014. p.19–30.
24. Mendoza JL, Tarriba JT, Reyes AI. Microsurgical management of severe human adjuvant disease due to mineral oil injection. Int Microsurg J 2020;4:1.